clostridium
Sanofi starts C. diff study
October 28, 2013Research and Development, Sales and Marketing C diff, Sanofi Pasteur, cdi, clostridium
Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
